Five-Year Downstream Outcomes Following Prostate-Specific Antigen Screening in Older Men

IMPORTANCE Despite ongoing controversies surrounding prostate-specific antigen (PSA) screening, many men 65 years or older undergo screening. However, few data exist that quantify the chain of events following screening in clinical practice to better inform decisions. OBJECTIVE To quantify 5-year do...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA internal medicine 2013-05, Vol.173 (10), p.1-8
Hauptverfasser:	Walter, Louise C, Fung, Kathy Z, Kirby, Katharine A, Shi, Ying, Espaldon, Roxanne, O’Brien, Sarah, Freedland, Stephen J, Powell, Adam A, Hoffman, Richard M
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Aged Aged, 80 and over Biological and medical sciences Biomarkers, Tumor - blood Biopsy Comorbidity Decision Making Early Detection of Cancer - adverse effects Early Detection of Cancer - methods Early Detection of Cancer - standards Erectile Dysfunction - epidemiology Erectile Dysfunction - etiology False Positive Reactions General aspects Humans Longitudinal Studies Male Mass Screening Medical Record Linkage Medical sciences Medicare Precision Medicine Prevention and actions Prostate-Specific Antigen - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - immunology Prostatic Neoplasms - prevention & control Prostatic Neoplasms - therapy Public health. Hygiene Public health. Hygiene-occupational medicine Risk Assessment Risk Factors Survival Analysis United States - epidemiology United States Department of Veterans Affairs Unnecessary Procedures Urinary Incontinence - epidemiology Urinary Incontinence - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!